SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2016 / Cilt: 58 - Sayı: 4

Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto- oncogene mutations

Özlem BOYBEYİ-TÜRER
DOĞUŞ VURALLI KARAOĞLAN
İbrahim KARNAK
Nazlı GÖNÇ
Emel Şule YALÇIN
Diclehan ORHAN
Nurgün KANDEMİR
Feridun Cahit TANYEL
Pages
436–441
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinicians and surgeons should be aware of critical timing for surgery and various surgical and clinical strategies in the management of MTC in children.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Boybeyi-Türer Ö, Vurallı D, Karnak İ, Gönç N, Yalçın EŞ, Orhan D, Kandemir N, Tanyel FC.
📊
Key Findings & Data:Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations.
💡
Conclusion & Impact:Clinicians and surgeons should be aware of critical timing for surgery and various surgical and clinical strategies in the management of MTC in children.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Boybeyi-Türer Ö, Vurallı D, Karnak İ, Gönç N, Yalçın EŞ, Orhan D, Kandemir N, Tanyel FC. Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations. Turk J Pediatr 2016; 58: 436-441.Medullary thyroid carcinoma (MTC) may arise sporadically or in familial manner. We presented sporadic and familial cases with MTC in order to raise awareness on management of such patients. Three medullary thyroid carcinoma (MTC) cases were presented. Case 1 had RET634 mutation; managed with total thyroidectomy (TT) and cervical lymph node dissection (CLND). Case 2 had RET804 mutation; managed with prophylactic TT. Case 3 had thyroid nodule; managed with TT and CLND. Case 1 had micro-carcinomatosis foci, Case 2 had normal thyroid tissue in histopathological examination and Case 3 had medullary thyroid carcinoma with tumor negative surgical borders. Case 1 was re-operated for persisting focus of disease. Follow-up of cases were uneventful. Clinicians and surgeons should be aware of critical timing for surgery and various surgical and clinical strategies in the management of MTC in children.

🔖

Cite This Article

BOYBEYİ-TÜRER, Ö., KARAOĞLAN, D. V., KARNAK, İ., GÖNÇ, N., YALÇIN, E. Ş., ORHAN, D., KANDEMİR, N., TANYEL, F. C. (2016). Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto- oncogene mutations. Turkish Journal of Pediatrics, Cilt: 58 - Sayı: 4, 436–441. https://ajindex.com/articles/412241

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Tavares MR, Toledo SP, Montenegro FL, et al. Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2. Clinics (Sao Paulo) 2012; 67: 149-154
  2. Morris LF, Waguespack SG, Edeiken-Monroe BS, et al. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. Ann Surg Oncol 2013; 20: 53-59
  3. Romei C, Pardi E, Cetani F, Elisei R. Genetic and clinical features of multiple endocrine neoplasia types 1 and 2. J Oncol 2012: 705036
  4. Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19: 565-612
  5. Wiersinga WM. Thyroid cancer in children and adolescents--consequences in later life. J Pediatr Endocrinol Metab 2001; 14: 1289-1296
  6. Spinelli C, Di Giacomo M, Costanzo S, Elisei R, Miccoli P. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes. J Pediatr Surg 2010; 45: 1610-1616
  7. Pacini F, Castagna MG, Cipri C, Schlumberger M. Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol) 2010; 22: 475-485
  8. Marsh DJ, Learoyd DL, Andrew SD, et al. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) 1996; 44: 249-257
  9. Elisei R, Romei C, Cosci B, et al. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab 2007; 92: 4725-4729
  10. Moline J, Eng C. Multiple endocrine neoplasia type 2: an overview. Genet Med 2011; 13: 755-764
  11. Miyauchi A, Futami H, Hai N, et al. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 1999; 90: 1-5
  12. Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 2000; 37: 817-827
  13. Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 2: 851-856
  14. Mulligan LM, Kwok JB, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458- 460
  15. Jarzab B, Szpak-Ulczok S, Wloch J, Czarniecka A, Krajewska J. Timing and